Intismeran autogene with pembrolizumab shows a 49% reduction in recurrence or death risk in high-risk resected melanoma ...
Moderna and Merck said on Tuesday their experimental personalized vaccine continued to cut the risk of death or recurrence of ...
A combination of intismeran autogene and Keytruda significantly prolonged recurrence-free survival in melanoma.
Patients with severe melanoma who received the treatment were 49% less likely to die or have their cancer return, ...
UnityPoint is expanding its specialty care services by opening three new clinics, including plastic surgery, in the Waukee ...
Chubbyemu on MSN
A farmer removed his own skin cancer with a pocket knife. This is what happened to his brain.
Curt Cignetti's on-brand stoic reaction to Indiana's punt block TD was amazing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback